Mathilde Simonnot, Pierre H Deprez, Mathieu Pioche, Eliane Albuisson, Timothée Wallenhorst, Fabrice Caillol, Stephane Koch, Emmanuel Coron, Isabelle Archambeaud, Jeremie Jacques, Paul Basile, Ludovic Caillo, Thibault Degand, Vincent Lépilliez, Philippe Grandval, Adrian Culetto, Geoffroy Vanbiervliet, Marine Camus Duboc, Olivier Gronier, Carina Leal, Jérémie Albouys, Jean-Baptiste Chevaux, Maximilien Barret, Marion Schaefer
BACKGROUND: Liver cirrhosis and esophageal cancer share several risk factors, such as alcohol intake and overweight. Endoscopic resection is the gold standard treatment for superficial tumors. Portal hypertension and coagulopathy may increase the bleeding risk in these patients. This study aims to assess the safety and efficacy of endoscopic resection for early esophageal neoplasia in patients with cirrhosis or portal hypertension. METHODS: This retrospective multicentric international study included consecutive patients with cirrhosis or portal hypertension who underwent endoscopic resection in the esophagus from January 2005 to March 2021...
May 3, 2023: Endoscopy